Methylprednisolone Export Market Intelligence: India's 355 Suppliers Shipping to 128 Countries — TransData Nexus 2026

Q: Who are the top methylprednisolone exporters from India?

The top methylprednisolone exporters from India are: 1. PAR FORMULATIONS PRIVATE LIMITED — $8.3M (28.2% market share); 2. ZYDUS LIFESCIENCES LIMITED — $4.0M (13.7% market share); 3. EUGIA PHARMA SPECIALITIES LIMITED — $3.0M (10.1% market share); 4. MYLAN LABORATORIES LIMITED — $2.6M (8.9% market share); 5. SWISS PARENTERALS LIMITED — $1.3M (4.5% market share). Together they account for 65.5% of India's total methylprednisolone export value.

Q: What is the total export value of methylprednisolone from India?

The total export value of methylprednisolone from India is $29.3M USD, recorded across 2,492 shipment transactions from 355 active exporters to 128 destination countries. The average shipment value is $11.8K.

Q: Which countries import methylprednisolone from India?

India exports methylprednisolone to 128 countries worldwide. The top importing countries are: UNITED STATES (70.0% share, $20.5M), ECUADOR (4.5% share, $1.3M), VIETNAM (1.8% share, $518.8K), SUDAN (1.4% share, $420.2K), MOROCCO (1.4% share, $409.0K). These five markets account for 79.1% of total export value.

Q: What is the average price of methylprednisolone exports from India?

The average unit price for methylprednisolone exports from India is $19.41 USD per unit, with prices ranging from $0.01 to $1174.41 depending on formulation, packaging, and order volume. The total market is valued at $29.3M across 2,492 shipments.

Q: Which ports handle methylprednisolone exports from India?

The primary ports for methylprednisolone exports from India are SAHAR AIR CARGO ACC (INBOM4) (24.6% of shipments), SAHAR AIR (19.3% of shipments), Bombay Air (5.5% of shipments), DELHI AIR CARGO ACC (INDEL4) (4.8% of shipments), NHAVA SHEVA SEA (INNSA1) (4.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of methylprednisolone?

India is one of the world's leading exporters of methylprednisolone due to its large base of 355 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports methylprednisolone to 128 countries, demonstrating 66% global market coverage.

Q: What certifications do Indian methylprednisolone exporters need?

Indian methylprednisolone exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import methylprednisolone from India?

There are 576 registered buyers importing methylprednisolone from India, spread across 128 countries. The repeat buyer rate is 53.0%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top methylprednisolone supplier from India?

PAR FORMULATIONS PRIVATE LIMITED is the leading methylprednisolone exporter from India with a market share of 28.2% and total export value of $8.3M across 44 shipments. The top 5 suppliers together control 65.5% of total export value.

Suresh Sormare

Methylprednisolone

India Pharmaceutical Trade Intelligence

$29.3M355 Suppliers128 CountriesHS 30049099

ExportsIndia → UNITED STATES70.0%India → ECUADOR4.5%

ImportsITALY → India$5.2B BELGIUM → India$689.0M

#1 Supplier: PAR FORMULATIONS #1 Buyer: EVERSANA LIFE

Methylprednisolone Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Methylprednisolone to the World

Between 2022 and 2026, India exported $29.3M worth of methylprednisolone across 2,492 verified shipments to 128 countries — covering 66% of world markets in the Corticosteroids segment. The largest destination is UNITED STATES (70.0%). PAR FORMULATIONS PRIVATE LIMITED leads with a 28.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Methylprednisolone export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Methylprednisolone export data snapshot — $29.3M · 355 exporters · 128 countriesTransData Nexus · Indian Customs Data

Top Methylprednisolone Exporters from India

355 active exporters · Ranked by export value

View all 355 →

Top Methylprednisolone Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	PAR FORMULATIONS PRIVATE LIMITED	$8.3M	44	1	28.2%
2	ZYDUS LIFESCIENCES LIMITED

Top Countries Importing Methylprednisolone from India

128 destination markets · Ranked by import value

All 128 countries →

Top Countries Importing Methylprednisolone from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$20.5M	70.0%
2	ECUADOR	$1.3M	4.5%
3	VIETNAM	$518.8K	1.8%
4	SUDAN	$420.2K	1.4%
5	MOROCCO	$409.0K	1.4%
6	VENEZUELA	$408.4K	1.4%
7	ALGERIA	$387.8K	1.3%
8	KAZAKHSTAN	$354.4K	1.2%
9	DOMINICAN REPUBLIC	$322.9K	1.1%
10	UNITED ARAB EMIRATES	$315.6K	1.1%

UNITED STATES is India's largest methylprednisolone export destination, absorbing 70.0% of total exports worth $20.5M. The top 5 importing countries — UNITED STATES, ECUADOR, VIETNAM, SUDAN, MOROCCO — together account for 79.1% of India's total methylprednisolone export value. The remaining 123 destination countries collectively receive the other 20.9%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Methylprednisolone to India?

8 origin countries · Total import value: $5.9B

India imports methylprednisolone from 8 countries with a combined import value of $5.9B. The largest supplier is ITALY ($5.2B, 98 shipments), followed by BELGIUM and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Methylprednisolone to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	ITALY	$5.2B	98	88.2%
2	BELGIUM	$689.0M	35	11.6%
3	UNITED STATES	$6.6M	212	0.1%
4	FRANCE	$3.4M	2	0.1%
5	CANADA	$6.2K	6	0.0%
6	IRELAND	$5.8K	2	0.0%
7	UNITED KINGDOM	$2.8K	2	0.0%
8	GERMANY	$883	6	0.0%

ITALY is the largest supplier of methylprednisolone to India, accounting for 88.2% of total import value. The top 5 origin countries — ITALY, BELGIUM, UNITED STATES, FRANCE, CANADA — together supply 100.0% of India's methylprednisolone imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Methylprednisolone

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, methylprednisolone is subject to rigorous regulatory oversight by the Food and Drug Administration (FDA). The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for methylprednisolone, indicating a competitive generic market. Notably, in October 2024, the FDA issued Import Alert 66-66, targeting Active Pharmaceutical Ingredients (APIs) that appear misbranded under section 502(f)(1) due to non-compliance with labeling exemptions specified in 21 CFR 201.122. This alert underscores the necessity for exporters to adhere strictly to FDA labeling requirements to avoid detention without physical examination.

Given that 70% of India's methylprednisolone exports are destined for the U.S., it is imperative for the 355 active Indian exporters to ensure compliance with FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), methylprednisolone is regulated by the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), respectively. Marketing authorization holders must comply with EU Good Manufacturing Practice (GMP) standards to ensure product quality and safety. In August 2024, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommended updates to the product information for methylprednisolone, highlighting the risk of Thyrotoxic Periodic Paralysis. This underscores the importance of continuous pharmacovigilance and adherence to updated regulatory guidelines. (ema.europa.eu)

3WHO Essential Medicines & Global Standards

Methylprednisolone is included in the World Health Organization's (WHO) Model List of Essential Medicines, reflecting its critical role in healthcare systems worldwide. The drug is recognized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality parameters across different regions.

4India Regulatory Classification

In India, methylprednisolone is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing to ensure affordability. Exporters are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

Methylprednisolone is a well-established pharmaceutical compound with expired patents, allowing for generic competition. This has led to a diversified market with multiple manufacturers producing the drug, contributing to its widespread availability and competitive pricing.

6Recent Industry Developments

In October 2024, the FDA issued Import Alert 66-66, emphasizing the need for compliance with labeling requirements for APIs, including methylprednisolone.

In August 2024, the EMA's PRAC recommended updates to the product information for methylprednisolone, highlighting the risk of Thyrotoxic Periodic Paralysis. (ema.europa.eu)

In March 2018, Sagent Pharmaceuticals issued a voluntary nationwide recall of methylprednisolone sodium succinate for injection due to high out-of-specification impurity results, underscoring the importance of stringent quality control measures.

These developments highlight the dynamic regulatory landscape surrounding methylprednisolone, necessitating continuous monitoring and compliance by manufacturers and exporters to ensure market access and patient safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Methylprednisolone

Retail & reference prices across 9 markets vs. India FOB export price of $19.41/unit

Global Price Benchmark for Methylprednisolone across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.19	USD	According to the FDA Orange Book, Methylprednisolone is available as a generic medication, contributing to its affordability.
United Kingdom	$0.20	GBP	The NHS Drug Tariff lists Methylprednisolone, ensuring standardized pricing across the UK.
Germany	$0.20	EUR	The German Federal Joint Committee (G-BA) includes Methylprednisolone in its pharmaceutical guidelines, influencing its pricing within the statutory health insurance system.
Australia

Supply Chain Risk Assessment — Methylprednisolone

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Methylprednisolone, a corticosteroid widely used for its anti-inflammatory properties, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency is part of a broader trend where 41% of KSMs used in U.S.-approved APIs are solely sourced from China, and 16% from India, as reported by the U.S. Pharmacopeia in October 2025.

Recent geopolitical tensions and regulatory actions have exacerbated this vulnerability. In March 2026, conflicts in the Middle East disrupted critical shipping routes, including the Strait of Hormuz, leading to significant delays and increased costs in the transportation of pharmaceutical ingredients. Additionally, China's stringent environmental regulations have led to the shutdown of several chemical manufacturing plants, causing supply disruptions and price escalations for essential KSMs.

2Supplier Concentration & Single-Source Risk

Our proprietary data indicates that the top five Indian exporters of Methylprednisolone account for 65.5% of total exports, with PAR Formulations Private Limited alone contributing 28.2%. This high supplier concentration poses a significant risk, as any operational or regulatory issues affecting these key players could disrupt the global supply chain.

Access Complete Methylprednisolone Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,492 transactions across 128 markets.

Request Demo View Pricing

Frequently Asked Questions — Methylprednisolone Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top methylprednisolone exporters from India?

The leading methylprednisolone exporters from India are PAR FORMULATIONS PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, and 12 others. PAR FORMULATIONS PRIVATE LIMITED leads with 28.2% market share ($8.3M). The top 5 suppliers together control 65.5% of total export value.

What is the total export value of methylprednisolone from India?

The total export value of methylprednisolone from India is $29.3M, recorded across 2,492 shipments from 355 active exporters to 128 countries. The average shipment value is $11.8K.

Which countries import methylprednisolone from India?

India exports methylprednisolone to 128 countries. The top importing countries are UNITED STATES (70.0%), ECUADOR (4.5%), VIETNAM (1.8%), SUDAN (1.4%), MOROCCO (1.4%), which together account for 79.1% of total export value.

What is the HS code for methylprednisolone exports from India?

The primary HS code for methylprednisolone exports from India is . This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Methylprednisolone

Methylprednisolone

Top Methylprednisolone Exporters from India

Top Countries Importing Methylprednisolone from India

Who Supplies Methylprednisolone to India?

Quick Facts

Related Corticosteroids

Related Analysis

Need Details?

Regulatory Landscape — Methylprednisolone

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Methylprednisolone

Supply Chain Risk Assessment — Methylprednisolone

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Methylprednisolone Trade Intelligence

Frequently Asked Questions — Methylprednisolone Exports from India

Who are the top methylprednisolone exporters from India?

What is the total export value of methylprednisolone from India?

Which countries import methylprednisolone from India?

What is the HS code for methylprednisolone exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of methylprednisolone exports from India?

Which ports handle methylprednisolone exports from India?

Why is India a leading exporter of methylprednisolone?

What certifications do Indian methylprednisolone exporters need?

How many buyers import methylprednisolone from India?

What is the market share of the top methylprednisolone exporter from India?

Analysis Methodology